Stocks to Watch Today: TCS, Zydus Lifesciences, RPP Infra Projects, LIC Housing, Galaxy Surfactants, Route Mobile in focus on 6 March
Stocks like Wipro, Walchandnagar Industries, Hindustan Zinc, R Systems International, Kirloskar Industries, Zaggle Prepaid Ocean Services, Dalmia Bharat, Sterlite Technologies, Banswara Syntex, ...
Wall Street Journal16d
Zydus Lifesciences Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Business Standard21d
Zydus launches vaccine for protection against new strain of influenza virus
Zydus Lifesciences on Wednesday said it is introducing a vaccine for protection against new strain of influenza virus. The company is introducing country's first flu protection quadrivalent influenza ...
The Hindu21d
Zydus launches vaccine for new strain of influenza virus
Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...
The Financial Express21d
Zydus Lifesciences launches flu vaccine in India to combat new influenza strain
(Image Credits: Freepik) Zydus on Wednesday announced that it is ready to launch the season’s first India’s Flu protection as per WHO recommended composition of quadrivalent influenza virus ...
money.rediff21d
Zydus Launches Quadrivalent Flu Vaccine: VaxiFlu-4
Zydus Lifesciences introduces India's first quadrivalent influenza vaccine, VaxiFlu-4, offering protection against four new strains of the virus. The vaccine, developed at Zydus's Vaccine Technology ...
Business Line22d
Zydus Lifesciences to launch VaxiFlu-4 for new influenza strain
Ahmedabad-based Zydus Lifesciences is set to launch the vaccine VaxiFlu-4 to combat a new strain of the influenza virus, as per the WHO-recommended composition of quadrivalent influenza virus ...
Business Standard23d
Zydus Life receives USFDA approval for manufacturing Ibuprofen and Famotidine tablets
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...
Pharmabiz23d
Zydus receives US FDA final approval for generic Duexis tablets, 800 mg/26.6 mg
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...
Daily25d
Zydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis
Ahmedabad: Zydus Lifesciences Limited has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine ...
moneycontrol.com26d
Indian pharma players can deliver 100 new drugs by 2047: Zydus Chairman
Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and development efforts, Zydus Lifesciences Chairman Pankaj R Patel said on Friday.